Caduet Articles

Payers’ outlook for Pfizer’s Lipitor generic strategy not rosy; second Caduet copy launched by Ranbaxy

6 December 2011

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA

2 December 2011

Mylan in patent settlement deals with Pfizer over Caduet and Lipitor

26 January 2011

Almirall to co-market Pfizer's Caduet in Spain under Astucor brand

17 November 2008

Pfizer

23 July 2007

Pfizer's 1st-qtr profits tumble 17.5%

30 April 2007

Pfizer to cut 10,000 jobs to maintain growth prospects ahead of tough environment

29 January 2007

Generics "striking at the heart of the antihypertensives market," Datamonitor

27 November 2006

Pfizer's Caduet reduces 10-yr CV risk by 54%

23 October 2006

Pfizer's 1st-qtr 2006 sees $4.11B income, return to form after major year-ago charges

24 April 2006

Pfizer accused of "influencing" Canadian doctors with payment for survey

13 February 2006

Pfizer sees earnings down but beats expectations, and Lipitor still growing

30 January 2006

US volume Rx sales rise 8.3% in 2004

21 February 2005

New product launches in 2004

31 January 2005

Statins to open door for more US OTC switches?

20 September 2004

Combination drugs the new fight against generics?

19 July 2004

US Rx drug sales up 11.5% in 2003, growth sustained by new products, says IMS

23 February 2004

Stock Commentary - Europe

16 February 2004

Stock Commentary - New York

9 February 2004

Pfizer's Caduet gets OK from FDA

9 February 2004

Showing 1-20 of 20 articles

Go to beginningPrevious
  • 1
NextGo to end